Bruce Fireman to Heptavalent Pneumococcal Conjugate Vaccine
This is a "connection" page, showing publications Bruce Fireman has written about Heptavalent Pneumococcal Conjugate Vaccine.
Connection Strength
0.245
-
Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine. 2006 Apr 12; 24 Suppl 2:S2-79-80.
Score: 0.068
-
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004 Jun; 23(6):485-9.
Score: 0.060
-
Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003 Jan; 22(1):10-6.
Score: 0.054
-
Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association between Kawasaki disease and seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2009 May; 28(5):438-40.
Score: 0.021
-
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J. 2006 Sep; 25(9):779-81.
Score: 0.018
-
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002 Sep; 21(9):810-5.
Score: 0.013
-
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J. 1999 Sep; 18(9):757-63.
Score: 0.011